In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaukos Holds Lead In Microinvasive Glaucoma Surgery

Executive Summary

Glaukos has emerged as the leader in microinvasive glaucoma surgery, a new treatment for the multibillion-dollar market. CEO Tom Burns lays out his vision for his company and for the future of MIGS.

Advertisement

Related Content

Glaukos' Micro-Bypass Stents Work As First-Line Glaucoma Therapy
Minimally Invasive Glaucoma Device Guidance Finalized
Finding The Fit For Ophthalmology In The New Pfizer
Ophthalmology Surgeons, Companies Finding Solutions In Medtech
Allergan Adds Device To Glaucoma Portfolio
All Eyes On Ophthalmic Devices Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel